Related Experiment Video
Updated: Jan 26, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
Novel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer
Shingo Miyamoto1,2, Takumi Narita1, Masami Komiya1
1Division of Prevention, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Abstract:
In conventional research methods for cancer prevention, cell proliferation and apoptosis have been intensively targeted rather than the protection of normal or benign tumor cells from malignant transformation. In this study, we aimed to identify candidate colon cancer chemopreventive drugs based on the transcriptional activities of TCF/LEF, NF-κB and NRF2, that play important roles in the process of malignant transformation. We screened a "validated library" consisting of 1280 approved drugs to identify hit compounds that decreased TCF/LEF and NF-κB transcriptional activity and increased NRF2 transcriptional activity. Based on the evaluation of these 3 transcriptional activities, 8 compounds were identified as candidate chemopreventive drugs for colorectal cancer. One of those, itraconazole, is a clinically used anti-fungal drug and was examined in the Min mouse model of familial adenomatous polyposis. Treatment with itraconazole significantly suppressed intestinal polyp formation and the effects of itraconazole on transcriptional activities may be exerted partly through inhibition of intracellular cholesterol trafficking. This screen represents one of the first attempts to identify chemopreventive agents using integrated criteria consisting of the inhibition of TCF/LEF, NF-κB and induction of NRF2 transcriptional activity.
Insights
This study identified 8 potential colon cancer chemopreventive drugs by screening 1280 compounds. Itraconazole, an antifungal, significantly reduced intestinal polyps in mice by modulating key cellular pathways.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Conventional cancer prevention often targets cell proliferation and apoptosis, neglecting normal cell protection.
- Malignant transformation involves critical transcriptional activities of TCF/LEF, NF-κB, and NRF2.
- Developing novel chemopreventive strategies is crucial for colorectal cancer (CRC).
Purpose of the Study:
- To identify candidate colon cancer chemopreventive drugs.
- To screen for compounds modulating TCF/LEF, NF-κB, and NRF2 transcriptional activity.
- To evaluate drug efficacy in a preclinical model.
Main Methods:
- Screening a library of 1280 approved drugs.
- Assessing compounds for decreased TCF/LEF and NF-κB activity, and increased NRF2 activity.
- Utilizing the Min mouse model to test candidate itraconazole efficacy.
Main Results:
- Eight compounds were identified as potential CRC chemopreventive agents.
- Itraconazole, an antifungal drug, significantly suppressed intestinal polyp formation in the Min mouse model.
- Itraconazole's effects may involve inhibiting intracellular cholesterol trafficking.
Conclusions:
- This study presents a novel approach for identifying chemopreventive agents using integrated transcriptional activity criteria.
- Itraconazole shows promise as a chemopreventive drug for colorectal cancer.
- Targeting TCF/LEF, NF-κB, and NRF2 pathways offers a new avenue for cancer prevention research.
More Related Videos
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Related Concept Videos
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cholesterol: Significance and Regulation
Considering cholesterol and...
The Colonization of Land
Intracellular Signaling Cascades
Prevention of Further Absorption of Poison